News
19 November
2020

“Nasz biznes zależy od ludzi i kapitału, a nie od miejsca” – Puls Biznesu article

“We know from the market that contracts in which medium or small companies resell in the preclinical or early clinical phase, for example, bispecific antibodies in immuno-oncological indications,  (…) may amount to several dozen million USD in upfront payments. We would like the commercialization of Pure Biologics’ immuno-oncology projects to look like this in the future.”

An article about Pure Biologics in “Puls Biznesu”, 19.11.2020.

An interview with Filip Jeleń, Romuald Harwas and Przemysł Jurek.

Read about the company’s business model, stock exchange plans and the biotechnology market in Poland.

Article: 📰 “Nasz biznes zależy od ludzi i kapitału, a nie od miejsca” (🇵🇱)

Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.

Pure Biologics - Harnessing the power of antibodies and aptamers